×
Scienture Holdings EBIT 2013-2024 | SCNX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Scienture Holdings ebit from 2013 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Scienture Holdings EBIT 2013-2024 | SCNX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Scienture Holdings ebit from 2013 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$114.1B
Cencora (COR)
$43.3B
DiDi Global (DIDIY)
$24.3B
ICON (ICLR)
$24.2B
Avantor (AVTR)
$17.2B
Natera (NTRA)
$16.1B
Revvity (RVTY)
$15.3B
BioMerieux (BMXMF)
$13.9B
Viatris (VTRS)
$13.8B
CochLear (CHEOY)
$13.1B
Solventum (SOLV)
$11.7B
Medpace Holdings (MEDP)
$10.6B
Charles River Laboratories (CRL)
$9.8B
Sonic Healthcare (SKHHY)
$8.9B
Doximity (DOCS)
$8.1B
HealthEquity (HQY)
$7.3B
Bausch + Lomb (BLCO)
$6.7B
PACS (PACS)
$5.9B
Life Times (LTH)
$5B
Organon (OGN)
$4.7B
Sotera Health (SHC)
$4.5B
Surgery Partners (SGRY)
$4B
GoodRx Holdings (GDRX)
$2.7B
Concentras Parent (CON)
$2.7B
Ardent Health Partners (ARDT)
$2.6B
BrightSpring Health Services (BTSG)
$2.5B
Alignment Healthcare (ALHC)
$2.1B
Ryman Healthcare (RYHTY)
$2B
Premier (PINC)
$1.9B
CareDx (CDNA)
$1.6B